Investor Relations

Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.

Latest News

Belfast investor presentation
17 February 2020
Director/PDMR Shareholding
03 February 2020
Trading update
29 January 2020

View Share Price

Share Price

GBp

updated every 15 minutes

Read more about us

Fusion Antibodies Company Profile

Read More »

View Investor Videos

Investor Videos

Watch latest video »

Sign up for Investor Alerts

Investor Alert

Sign up for Investor Alerts »